La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Enwei Pharmaceutical Salute del bilancio
Salute finanziaria criteri di controllo 6/6
Enwei Pharmaceutical has a total shareholder equity of CN¥1.1B and total debt of CN¥34.3M, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are CN¥1.4B and CN¥276.0M respectively. Enwei Pharmaceutical's EBIT is CN¥70.3M making its interest coverage ratio -18.8. It has cash and short-term investments of CN¥371.5M.
Informazioni chiave
3.2%
Rapporto debito/patrimonio netto
CN¥34.28m
Debito
| Indice di copertura degli interessi | -18.8x |
| Contanti | CN¥371.53m |
| Patrimonio netto | CN¥1.08b |
| Totale passività | CN¥275.99m |
| Totale attività | CN¥1.36b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Analisi della posizione finanziaria
Passività a breve termine: 301331's short term assets (CN¥796.4M) exceed its short term liabilities (CN¥219.2M).
Passività a lungo termine: 301331's short term assets (CN¥796.4M) exceed its long term liabilities (CN¥56.8M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 301331 has more cash than its total debt.
Riduzione del debito: 301331's debt to equity ratio has reduced from 5.5% to 3.2% over the past 5 years.
Copertura del debito: 301331's debt is well covered by operating cash flow (261.3%).
Copertura degli interessi: 301331 earns more interest than it pays, so coverage of interest payments is not a concern.